STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Clinical trials for STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lung cancer combo after surgery fails to extend life
Disease control CompletedThis large phase III trial tested whether adding bevacizumab (Avastin) to standard chemotherapy after complete lung cancer surgery could help patients live longer. Over 1,500 patients with stage IB to IIIA non-small cell lung cancer took part. The study found that adding bevacizu…
Matched conditions: STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Immunotherapy before surgery shrinks lung tumors in Early-Stage trial
Disease control CompletedThis study tested giving immunotherapy drugs (nivolumab alone or with ipilimumab) or immunotherapy plus chemotherapy before surgery for people with early-stage non-small cell lung cancer (stages I to IIIA). The goal was to see if these treatments could shrink or eliminate the tum…
Matched conditions: STAGE IIB LUNG NON-SMALL CELL CARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC